Mitochondrial fusion proteins: Dual regulators of morphology and metabolism

Seminars in Cell and Developmental Biology

Volumn 21, Issue 6, 2010, Pages 566-574

  Zorzano, Antonio ^a,b,c   Liesa, Marc ^a,b,c   Sebastián, David ^a,b,c   Segalés, Jessica ^a,b,c   Palacín, Manuel ^a,b  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Mitochondrial fusion; Mitochondrial metabolism; Mitofusin; OPA1; PGC 1 ; PGC 1

Indexed keywords

CELL PROTEIN; MITOFUSIN 1; MITOFUSIN 2; PROTEIN OPA1; UNCLASSIFIED DRUG;

CELL CYCLE; CELL METABOLISM; CELL STRUCTURE; HUMAN; MITOCHONDRION; MITOCHONDRION FISSION; MITOCHONDRION FUSION; NONHUMAN; REVIEW;

MAMMALIA;

EID: 77955276765     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2010.01.002     Document Type: Review

References (86)

1. Lewis M.R., Lewis W.H. Mitochondria in tissue culture. Science 1914, 39:330-333.
2. Thomas D.Y., Wilkie D. Recombination of mitochondrial drug-resistance factors in Saccharomyces cerevisiae. Biochem Biophys Res Commun 1968, 30:368.
3. Bakeeva L.E., Chentsov Y.S., Skulachev V.P. Ontogenesis of mitochondrial reticulum in rat diaphragm muscle. Eur J Cell Biol 1981, 25:175-181.
4. Bakeeva L.E., Chentsov Y.S., Skulachev V.P. Mitochondrial framework (reticulum mitochondrial) in rat diaphragm muscle. Biochim Biophys Acta 1978, 501:349-369.
5. Kimberg D.V., Loeb J.N. Effects of cortisone administration on rat-liver mitochondria-support for concept of mitochondrial fusion. J Cell Biol 1972, 55:635.
6. Nunnari J., Marshall W.F., Straight A., Murray A., Sedat J.W., Walter P. Mitochondrial transmission during mating in Saccharomyces cerevisiae is determined by mitochondrial fusion and fission and the intramitochondrial segregation of mitochondrial DNA. Mol Biol Cell 1997, 8:1233-1242.
7. Bereiter-Hahn J., Voth M. Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microsc Res Tech 1994, 27:198-219.
8. Cortese J.D., Voglino L.A., Hackenbrock C.R. Novel fluorescence membrane fusion assays reveal GTP-dependent fusogenic properties of outer mitochondrial membrane-derived proteins. Biochim Biophys Acta 1998, 1371:185-198.
9. Hales K.G., Fuller M.T. Developmentally regulated mitochondrial fusion mediated by a conserved, novel, predicted GTPase. Cell 1997, 90:121-129.
10. Yaffe M.P. The machinery of mitochondrial inheritance and behavior. Science 1999, 283:1493-1497.
11. Malka F., Guillery O., Cifuentes-Diaz C., Guillou E., Belenguer P., Lombes A., et al. Separate fusion of outer and inner mitochondrial membranes. EMBO Rep 2005, 6:853-859.
12. Liesa M., Palacin M., Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiol Rev 2009, 89:799-845.
13. Santel A., Fuller M.T. Control of mitochondrial morphology by a human mitofusin. J Cell Sci 2001, 114:867-874.
14. Koshiba T., Detmer S.A., Kaiser J.T., Chen H., McCaffery J.M., Chan D.C. Structural basis of mitochondrial tethering by mitofusin complexes. Science 2004, 305:858-862.
15. Chen H., Detmer S.A., Ewald A.J., Griffin E.E., Fraser S.E., Chan D.C. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 2003, 160:189-200.
16. Bourne H.R., Sanders D.A., McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature 1990, 348:125-132.
17. Bourne H.R., Sanders D.A., McCormick F. The GTPase superfamily: conserved structure and molecular mechanism. Nature 1991, 349:117-127.
18. Santel A., Frank S., Gaume B., Herrler M., Youle R.J., Fuller M.T. Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. J Cell Sci 2003, 116:2763-2774.
19. Chen H., McCaffery J.M., Chan D.C. Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 2007, 130:548-562.
20. Cartoni R., Leger B., Hock M.B., Praz M., Crettenand A., Pich S., et al. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J Physiol 2005, 567:349-358.
21. Nisoli E., Tonello C., Cardile A., Cozzi V., Bracale R., Tedesco L., et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005, 310:314-317.
22. Rojo M., Legros F., Chateau D., Lombes A. Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. J Cell Sci 2002, 115:1663-1674.
23. Eura Y., Ishihara N., Yokota S., Mihara K. Two mitofusin proteins, mammalian homologues of FZO, with distinct functions are both required for mitochondrial fusion. J Biochem (Tokyo) 2003, 134:333-344.
24. Bach D., Pich S., Soriano F.X., Vega N., Baumgartner B., Oriola J., et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem 2003, 278:17190-17197.
25. Chen K.H., Guo X., Ma D., Guo Y., Li Q., Yang D., et al. Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol 2004, 6:872-883.
26. de Brito O.M., Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 2008, 456:605-610.
27. Honda S., Aihara T., Hontani M., Okubo K., Hirose S. Mutational analysis of action of mitochondrial fusion factor mitofusin-2. J Cell Sci 2005, 118:3153-3161.
28. Ishihara N., Eura Y., Mihara K. Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity. J Cell Sci 2004, 117:6535-6546.
29. Neuspiel M., Zunino R., Gangaraju S., Rippstein P., McBride H. Activated mitofusin 2 signals mitochondrial fusion, interferes with Bax activation, and reduces susceptibility to radical induced depolarization. J Biol Chem 2005, 280:25060-25070.
30. Huang P., Yu T., Yoon Y. Mitochondrial clustering induced by overexpression of the mitochondrial fusion protein Mfn2 causes mitochondrial dysfunction and cell death. Eur J Cell Biol 2007, 86:289-302.
31. Guillery O., Malka F., Landes T., Guillou E., Blackstone C., Lombes A., et al. Metalloprotease-mediated OPA1 processing is modulated by the mitochondrial membrane potential. Biol Cell 2008, 100:315-325.
32. Zuchner S., Mersiyanova I.V., Muglia M., Bissar-Tadmouri N., Rochelle J., Dadali E.L., et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004, 36:449-451.
33. Bach D., Naon D., Pich S., Soriano F.X., Vega N., Rieusset J., et al. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes 2005, 54:2685-2693.
34. Delettre C., Lenaers G., Griffoin J.M., Gigarel N., Lorenzo C., Belenguer P., et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000, 26:207-210.
35. Alexander C., Votruba M., Pesch U.E., Thiselton D.L., Mayer S., Moore A., et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 2000, 26:211-215.
36. Cipolat S., Martins d.B., Dal Zilio B., Scorrano L. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc Natl Acad Sci USA 2004, 101:15927-15932.
37. Griparic L., van der Wel N.N., Orozco I.J., Peters P.J., van der Bliek A.M. Loss of the intermembrane space protein Mgm1/OPA1 induces swelling and localized constrictions along the lengths of mitochondria. J Biol Chem 2004, 279:18792-18798.
38. Ishihara N., Fujita Y., Oka T., Mihara K. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J 2006, 25:2966-2977.
39. Olichon A., Baricault L., Gas N., Guillou E., Valette A., Belenguer P., et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 2003, 278:7743-7746.
40. Akepati V.R., Muller E.C., Otto A., Strauss H.M., Portwich M., Alexander C. Characterization of OPA1 isoforms isolated from mouse tissues. J Neurochem 2008, 106:372-383.
41. Olichon A., Emorine L.J., Descoins E., Pelloquin L., Brichese L., Gas N., et al. The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space. FEBS Lett 2002, 523:171-176.
42. Satoh M., Hamamoto T., Seo N., Kagawa Y., Endo H. Differential sublocalization of the dynamin-related protein OPA1 isoforms in mitochondria. Biochem Biophys Res Commun 2003, 300:482-493.
43. Olichon A., Landes T., Arnaune-Pelloquin L., Emorine L.J., Mils V., Guichet A., et al. Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis. J Cell Physiol 2007, 211:423-430.
44. Delettre C., Griffoin J.M., Kaplan J., Dollfus H., Lorenz B., Faivre L., et al. Mutation spectrum and splicing variants in the OPA1 gene. Hum Genet 2001, 109:584-591.
45. Olichon A., Elachouri G., Baricault L., Delettre C., Belenguer P., Lenaers G. OPA1 alternate splicing uncouples an evolutionary conserved function in mitochondrial fusion from a vertebrate restricted function in apoptosis. Cell Death Differ 2007, 14:682-692.
46. Duvezin-Caubet S., Jagasia R., Wagener J., Hofmann S., Trifunovic A., Hansson A., et al. Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology. J Biol Chem 2006, 281:37972-37979.
47. Song Z., Chen H., Fiket M., Alexander C., Chan D.C. OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J Cell Biol 2007, 178:749-755.
48. Arnoult D., Grodet A., Lee Y.J., Estaquier J., Blackstone C. Release of OPA1 during apoptosis participates in the rapid and complete release of cytochrome c and subsequent mitochondrial fragmentation. J Biol Chem 2005, 280:35742-35750.
49. Cipolat S., Rudka T., Hartmann D., Costa V., Serneels L., Craessaerts K., et al. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 2006, 126:163-175.
50. Duvezin-Caubet S., Koppen M., Wagener J., Zick M., Israel L., Bernacchia A., et al. OPA1 processing reconstituted in yeast depends on the subunit composition of the m-AAA protease in mitochondria. Mol Biol Cell 2007, 18:3582-3590.
51. Frezza C., Cipolat S., Martins d.B., Micaroni M., Beznoussenko G.V., Rudka T., et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 2006, 126:177-189.
52. Griparic L., Kanazawa T., van der Bliek A.M. Regulation of the mitochondrial dynamin-like protein Opa1 by proteolytic cleavage. J Cell Biol 2007, 178:757-764.
53. Chen H., Chomyn A., Chan D.C. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem 2005, 280:26185-26192.
54. Lee Y.J., Jeong S.Y., Karbowski M., Smith C.L., Youle R.J. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell 2004, 15:5001-5011.
55. Twig G., Elorza A., Molina A.J., Mohamed H., Wikstrom J.D., Walzer G., et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 2008, 27:433-446.
56. Alavi M.V., Bette S., Schimpf S., Schuettauf F., Schraermeyer U., Wehrl H.F., et al. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy. Brain 2007, 130:1029-1042.
57. Davies V.J., Hollins A.J., Piechota M.J., Yip W., Davies J.R., White K.E., et al. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum Mol Genet 2007, 16:1307-1318.
58. Eura Y., Ishihara N., Oka T., Mihara K. Identification of a novel protein that regulates mitochondrial fusion by modulating mitofusin (Mfn) protein function. J Cell Sci 2006, 119:4913-4925.
59. Delivani P., Adrain C., Taylor R.C., Duriez P.J., Martin S.J. Role for CED-9 and Egl-1 as regulators of mitochondrial fission and fusion dynamics. Mol Cell 2006, 21:761-773.
60. Hajek P., Chomyn A., Attardi G. Identification of a novel mitochondrial complex containing mitofusin 2 and stomatin-like protein 2. J Biol Chem 2007, 282:5670-5681.
61. Nakamura N., Kimura Y., Tokuda M., Honda S., Hirose S. MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology. EMBO Rep 2006, 7:1019-1022.
62. Cereghetti G.M., Stangherlin A., Martins d.B., Chang C.R., Blackstone C., Bernardi P., et al. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc Natl Acad Sci USA 2008, 105:15803-15808.
63. Chang C.R., Blackstone C. Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology. J Biol Chem 2007, 282:21583-21587.
64. Cribbs J.T., Strack S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep 2007, 8:939-944.
65. Taguchi N., Ishihara N., Jofuku A., Oka T., Mihara K. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem 2007, 282:11521-11529.
66. Wasiak S., Zunino R., McBride H.M. Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death. J Cell Biol 2007, 177:439-450.
67. Cho D.H., Nakamura T., Fang J., Cieplak P., Godzik A., Gu Z., et al. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 2009, 324:102-105.
68. James D.I., Parone P.A., Mattenberger Y., Martinou J.C. hFis1, a novel component of the mammalian mitochondrial fission machinery. J Biol Chem 2003, 278:36373-36379.
69. Yoon Y., Krueger E.W., Oswald B.J., McNiven M.A. The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1. Mol Cell Biol 2003, 23:5409-5420.
70. Kelley D.E., He J., Menshikova E.V., Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002, 51:2944-2950.
71. Soriano F.X., Liesa M., Bach D., Chan D.C., Palacin M., Zorzano A. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2. Diabetes 2006, 55:1783-1791.
72. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92:829-839.
73. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003, 34:267-273.
74. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 2003, 100:8466-8471.
75. Arany Z., He H., Lin J., Hoyer K., Handschin C., Toka O., et al. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab 2005, 1:259-271.
76. Staiger H., Stefan N., Machicao F., Fritsche A., Haring H.U. PPARGC1A mRNA levels of in vitro differentiated human skeletal muscle cells are negatively associated with the plasma oleate concentrations of the donors. Diabetologia 2006, 49:212-214.
77. Lelliott C.J., Medina-Gomez G., Petrovic N., Kis A., Feldmann H.M., Bjursell M., et al. Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol 2006, 4:e369.
78. Vianna C.R., Huntgeburth M., Coppari R., Choi C.S., Lin J., Krauss S., et al. Hypomorphic mutation of PGC-1beta causes mitochondrial dysfunction and liver insulin resistance. Cell Metab 2006, 4:453-464.
79. Liesa M., Borda-d'Agua B., Medina-Gomez G., Lelliott C.J., Paz J.C., Rojo M., et al. Mitochondrial fusion is increased by the nuclear coactivator PGC-1beta. PLoS ONE 2008, 3:e3613.
80. St Pierre J., Lin J., Krauss S., Tarr P.T., Yang R., Newgard C.B., et al. Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem 2003, 278:26597-26603.
81. Pich S., Bach D., Briones P., Liesa M., Camps M., Testar X., et al. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum Mol Genet 2005, 14:1405-1415.
82. Loiseau D., Chevrollier A., Verny C., Guillet V., Gueguen N., Pou de Crescenzo M.A., et al. Mitochondrial coupling defect in Charcot-Marie-Tooth type 2A disease. Ann Neurol 2007, 61:315-323.
83. Amiott E.A., Lott P., Soto J., Kang P.B., McCaffery J.M., DiMauro S., et al. Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations. Exp Neurol 2008, 211:115-127.
84. Zanna C., Ghelli A., Porcelli A.M., Karbowski M., Youle R.J., Schimpf S., et al. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 2008, 131:352-367.
85. Mayorov V.I., Lowrey A.J., Biousse V., Newman N.J., Cline S.D., Brown M.D. Mitochondrial oxidative phosphorylation in autosomal dominant optic atrophy. BMC Biochem 2008, 9:22.
86. Spinazzi M., Cazzola S., Bortolozzi M., Baracca A., Loro E., Casarin A., et al. A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function. Hum Mol Genet 2008, 17:3291-3302.